APUS vs D · $2.4M cap vs P/E 21, rev $16.51B
Apimeds Pharmaceuticals US, Inc. (APUS) versus Dominion Energy Inc (D) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
Dominion Energy Inc (D) is a utilities - regulated electric company listed on US.
APUS does not have a complete income-statement cache yet.
Latest reported D revenue for 2025-12-31 was $16.51B. Net income was $3.00B. Revenue was up 385.5% from 2024-12-31 to 2025-12-31. D currently screens at market cap $47.07B and trailing P/E 21.3.
APUS currently screens at market cap $2.4M. D currently screens at market cap $47.07B and trailing P/E 21.3.
Not investment advice. Open the APUS and D stock pages for the full models.
Not investment advice.